Integra LifeSciences

Integra LifeSciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery. Integra's orthopedic products include devices and implants for spine, foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, and wound repair. Integra is a leader in neurosurgery, offering a broad portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. In the United States, Integra is a leading provider of surgical instruments to hospitals, surgery centers and alternate care sites, including physician and dental offices. Founded in 1989 Integra is headquartered in Plainsboro, New Jersey and has over 3,500 employees worldwide. Integra's common stock is listed on The NASDAQ Stock Market under the symbol "IART."
Company Growth (employees)
Type
Public
HQ
Plainsboro Center, US
Size (employees)
3,700 (est)+6%
Integra LifeSciences is headquartered in Plainsboro Center, US

Integra LifeSciences Office Locations

Integra LifeSciences has offices in Plainsboro Center, Oakville, York, Billerica and in 2 other locations
Plainsboro Center, US
Middlesex County, US
West Valley City, US
Billerica, US
York, US
Oakville, CA

Integra LifeSciences Metrics

Integra LifeSciences Summary

Market capitalization

$3.2 b

Closing share price

$43.2
Integra LifeSciences's current market capitalization is $3.2 b.

Integra LifeSciences Financials

Integra LifeSciences's revenue is $836.2 m in FY, 2013 which is a 9.9% decrease from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

$836.2 m$928.3 m$882.7 m$992.1 m

Revenue growth, %

11%(4.9%)12.4%

Cost of goods sold

$334.1 m$352.8 m$326.5 m$349.1 m

Gross profit

$556.2 m

Operating expense total

$505.8 m$510 m$476.6 m$876.7 m

EBIT

($3.6 m)$65.5 m$79.6 m$115.3 m

Interest expense

($19.8 m)($22 m)($23.5 m)($25.8 m)

Interest income

$443 k$168 k$13 k$24 k

Income tax expense

($7.8 m)$9 m$53.8 m$15.8 m

Pre tax profit

($24.8 m)$43 m$60.7 m$90.4 m

Net Income

($17 m)$34 m($3.5 m)$74.6 m

Operating cash flow

$23.7 m($48.6 m)($23.9 m)

Integra LifeSciences Market Value History

Integra LifeSciences Online Presence

Integra LifeSciences Company Life

You may also be interested in